AptarGroup Inc. (ATR)
| Bid | 141 |
| Market Cap | 10.03B |
| Revenue (ttm) | 3.55B |
| Net Income (ttm) | 370.24M |
| EPS (ttm) | 5.53 |
| PE Ratio (ttm) | 27.5 |
| Forward PE | 23.72 |
| Analyst | Buy |
| Ask | 155.98 |
| Volume | 367,695 |
| Avg. Volume (20D) | 395,153 |
| Open | 149.44 |
| Previous Close | 148.28 |
| Day's Range | 147.94 - 153.00 |
| 52-Week Range | 130.85 - 178.03 |
| Beta | 0.59 |
About ATR
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma...
Analyst Forecast
According to 4 analyst ratings, the average rating for ATR stock is "Buy." The 12-month stock price forecast is $170, which is an increase of 11.78% from the latest price.
Stock ForecastsEarnings Surprise
4 days ago · businesswire.com
Aptar Reports First Quarter 2025 ResultsCRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports First Quarter 2025 Results.
2 weeks ago · businesswire.com
Aptar Declares Quarterly DividendCRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend.
3 weeks ago · seekingalpha.com
AptarGroup: Strong Pharma And Closure Growth To Offset Beauty HeadwindsAptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. The prescription drug business is expected to drive revenue growth in the Pharma ...
